BriaCell Therapeutics Corp.
Cash Flow Statement
| Line Item | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.2M | $-7.2M | $-8.2M | $-8.1M | $-6.1M | $-6.3M | $-5.8M | $-1.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $29.2K | $22.8K | $22.8K | $22.8K | $22.8K | $22.8K | $22.8K | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $432.2K | $285.9K | $294.7K | $0 | $224.8K | $285.1K | $267.0K | $377.9K |
| Net Cash from Operating Activities | $-7.0M | $-8.0M | $-7.7M | $-8.1M | $-7.2M | $-5.9M | $-7.0M | $-4.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-16.0M | $7.3M | $-75.0K | $-7.4M | $-105.0K | $-75.0K | $-75.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | $13.6M | $14.7M | $5.2M | $12.0M | — |
| Net Change in Cash | $-23.0M | $27.2M | $-7.8M | $-2.0M | $7.4M | $-778.6K | $4.9M | $-73.6K |
| Free Cash Flow | — | — | — | — | — | — | — | — |